Sqz Biotechnologies Co (SQZ)

NYSE
11.88
+0.56(+4.95%)
After Hours
11.88
0.00(0.00%)
- Real-time Data
  • Volume:
    111,229
  • Bid/Ask:
    6.77/12.50
  • Day's Range:
    11.35 - 12.18

SQZ Overview

Prev. Close
11.32
Day's Range
11.35 - 12.18
Revenue
21M
Open
11.4
52 wk Range
11.15 - 36.49
EPS
-2.08
Volume
111,229
Market Cap
331.23M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
192,593
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
27,881,722
Next Earnings Date
Sep 01, 2021
What is your sentiment on Sqz Biotechnologies Co?
or
Market is currently closed. Voting is open during market hours.

Sqz Biotechnologies Co News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuySellSell
Technical IndicatorsBuyStrong SellStrong BuyStrong SellSell
SummaryStrong BuyNeutralStrong BuyStrong SellSell

Sqz Biotechnologies Co Company Profile

Sqz Biotechnologies Co Company Profile

Employees
98

SQZ Biotechnologies Company is a clinical-stage biotechnology company. The Company is developing transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. It uses its technology, Cell Squeeze, to physically squeeze cells through a microfluidic chip, temporarily opening the cell membrane and enabling biologic material of interest, or cargo, to diffuse into the cell. Its SQZ Antigen Presenting Cells (SQZ APC) platform is in a Phase I trial in highly immunogenic (HPV) plus tumors. It is also developing SQZ Activating Antigen Carriers (SQZ AAC) and SQZ Tolerizing Antigen Carriers (SQZ TAC). Its SQZ APC platform is focused on generating robust (cluster of differentiation 8 (CD8) plus T cell responses. Its lead product candidate, SQZ- peripheral blood mononuclear cells (PBMC)-HPV, from its SQZ APC platform, is a targeted cancer vaccine that has been designed to generate antigen-specific CD8 plus T cell responses to attack HPV plus tumors.

Read More
  • will skyrocket in the next 3 years
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.